Same-day discharge in endometrial cancer surgery: current evidence and future directions

Endometrial cancer, one of the most common gynecologic malignancies, is increasingly associated with obesity and an aging population. Our semi-systematic review evaluated the current evidence on same-day discharge (SDD) following endometrial cancer surgery and conducted a bibliometric analysis. A PubMed search (January 2025) identified 11 studies, including 44,230 patients, predominantly from high-income countries, with 81.8% undergoing minimally invasive surgery and 14.5% sentinel lymph node mapping. No mortalities were reported, and readmission rates ranged from 1.5% to 3.4%. Our findings suggest that SDD is a feasible and safe approach, particularly in North America and for minimally invasive procedures. However, research gaps remain regarding implementation in low- and middle-income countries and in populations with severe obesity or advanced age. Future studies should emphasize standardized reporting, patient selection criteria, and comparative analyses across healthcare systems.